Stock Track | LifeStance Health Soars 8.7% on Strong Q3 Results and Raised Guidance

Stock Track11-07

Shares of LifeStance Health Group, Inc. (LFST) surged 8.7% on November 7, 2024, driven by the company's impressive third-quarter 2024 financial results and an upward revision of its full-year guidance.

The outpatient mental healthcare provider reported a 19% year-over-year increase in revenue to $312.7 million, surpassing analysts' expectations of $302.6 million. The strong revenue growth was fueled by improvements in total revenue per visit and higher visit volumes from net clinician growth.

LifeStance's adjusted EBITDA more than doubled to $30.7 million, significantly exceeding the consensus estimate of $18.2 million. The company's adjusted EBITDA margin expanded to 9.8% of total revenue, up from 5.6% in the year-ago period, reflecting higher total revenue per visit, lower center costs as a percentage of revenue, and improved operating leverage.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154213856?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-07 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154213856","market":"us","top_or_hot":-1,"title":"Stock Track | LifeStance Health Soars 8.7% on Strong Q3 Results and Raised Guidance","media":"Stock Track","content":"<p>Shares of LifeStance Health Group, Inc. (LFST) surged 8.7% on November 7, 2024, driven by the company's impressive third-quarter 2024 financial results and an upward revision of its full-year guidance.</p>\n\n<p>The outpatient mental healthcare provider reported a 19% year-over-year increase in revenue to $312.7 million, surpassing analysts' expectations of $302.6 million. The strong revenue growth was fueled by improvements in total revenue per visit and higher visit volumes from net clinician growth.</p>\n\n<p>LifeStance's adjusted EBITDA more than doubled to $30.7 million, significantly exceeding the consensus estimate of $18.2 million. The company's adjusted EBITDA margin expanded to 9.8% of total revenue, up from 5.6% in the year-ago period, reflecting higher total revenue per visit, lower center costs as a percentage of revenue, and improved operating leverage.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | LifeStance Health Soars 8.7% on Strong Q3 Results and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | LifeStance Health Soars 8.7% on Strong Q3 Results and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-07 22:37 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of LifeStance Health Group, Inc. (LFST) surged 8.7% on November 7, 2024, driven by the company's impressive third-quarter 2024 financial results and an upward revision of its full-year guidance...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LFST","symbol_name":"LifeStance Health Group, Inc.","start_time":0,"source_url":"","article_id":"1154213856","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154213856","pubTimestamp":1730990273,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of LifeStance Health Group, Inc.  surged 8.7% on November 7, 2024, driven by the company's impressive third-quarter 2024 financial results and an upward revision of its full-year guidance.The outpatient mental healthcare provider reported a 19% year-over-year increase in revenue to $312.7 million, surpassing analysts' expectations of $302.6 million. The strong revenue growth was fueled by improvements in total revenue per visit and higher visit volumes from net clinician growth.LifeStance","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LFST":"LifeStance Health Group, Inc."},"translate_title":"股票赛道LifeStance Health因强劲的第三季度业绩和上调指引而飙升8.7%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFST":1},"content_text":"Shares of LifeStance Health Group, Inc. (LFST) surged 8.7% on November 7, 2024, driven by the company's impressive third-quarter 2024 financial results and an upward revision of its full-year guidance.\nThe outpatient mental healthcare provider reported a 19% year-over-year increase in revenue to $312.7 million, surpassing analysts' expectations of $302.6 million. The strong revenue growth was fueled by improvements in total revenue per visit and higher visit volumes from net clinician growth.\nLifeStance's adjusted EBITDA more than doubled to $30.7 million, significantly exceeding the consensus estimate of $18.2 million. The company's adjusted EBITDA margin expanded to 9.8% of total revenue, up from 5.6% in the year-ago period, reflecting higher total revenue per visit, lower center costs as a percentage of revenue, and improved operating leverage.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154213856"}